Why Do Magnesium Levels Drop With Certain Medications?

If your magnesium came back low and you're also taking a prescription medication, the two are very possibly connected — and this is one of the more common, well-documented, and frequently overlooked causes of magnesium deficiency in adults. Several widely prescribed drug classes, including diuretics, acid-reducing medications, certain antibiotics, immunosuppressants, and some cancer treatments, can each lower magnesium through their own distinct underlying biological mechanism, ranging from forcing the kidneys to excrete more of it, to blocking how efficiently your intestines absorb it in the first place, to directly damaging the kidney structures responsible for holding onto it. None of this means these medications are inherently dangerous or should be stopped on your own — most are prescribed precisely because their real, meaningful benefits clearly outweigh this particular, manageable side effect — but understanding exactly how and why it happens helps explain an otherwise confusing low result, and helps you have a more informed, productive conversation with your prescriber about ongoing monitoring and, if needed, appropriate supplementation. This article walks through how your body normally keeps magnesium balanced, which medication classes are most commonly involved and why, how magnesium interacts with other key electrolytes, how to recognize the symptoms of medication-related magnesium loss, and what typically happens once it's identified.

How Your Body Normally Keeps Magnesium in Balance

Figure 1. Healthy kidneys reabsorb roughly 95% of the magnesium filtered from blood, a finely tuned process several medications can disrupt.

Magnesium is involved in more than 300 different enzyme reactions throughout your body, supporting everything from muscle contraction and nerve signaling to energy production at the cellular level and the structural stability of your bones. Given how essential it is, your body maintains a remarkably tight system for keeping it in balance, relying primarily on two organs working in coordination: your intestines, which absorb magnesium from the food you eat, and your kidneys, which decide moment to moment how much of that absorbed magnesium to keep versus excrete in urine. Unlike some minerals that are tightly regulated by a dedicated hormone system, magnesium balance depends more on this direct interplay between intake, intestinal absorption efficiency, and kidney handling — which is part of why magnesium regulation is uniquely vulnerable to interference at several different points along that pathway.

Under normal circumstances, your kidneys filter a large amount of magnesium out of the blood every day, then reabsorb roughly 95% of it back into circulation before urine leaves the body, discarding only the small remainder. This reabsorption happens at several points along the kidney's tiny filtering units, called nephrons, with the largest share occurring in a segment called the thick ascending limb of the loop of Henle, and a smaller but finely adjustable portion occurring further along in the distal convoluted tubule. This two-stage system gives your kidneys real flexibility: when magnesium intake is low, they can ramp up reabsorption to conserve what's available; when intake is abundant, they can let more pass into urine. Medications that interfere with magnesium levels typically do so by disrupting one or more of these control points directly — either forcing the kidneys to release magnesium they would otherwise hold onto, or preventing the intestines from absorbing it in the first place — which is exactly why understanding each specific medication's mechanism matters so much for understanding, and eventually managing, the resulting deficiency.

Why Magnesium Deficiency From Medications Often Goes Undiagnosed

Magnesium occupies an unusual position in routine lab testing: unlike sodium, potassium, and calcium, which are almost always included in a standard basic or comprehensive metabolic panel, magnesium frequently isn't part of routine bloodwork unless a clinician specifically orders it separately. This means that even someone getting regular annual checkups, with what looks like a thorough panel of labs, may never actually have their magnesium checked unless a specific reason prompts their provider to add it — a genuine gap that helps explain why medication-related magnesium deficiency is thought to be considerably more common in the general population than it is actually diagnosed and documented in medical records.

Compounding this, blood magnesium testing itself has a well-known limitation: standard serum magnesium reflects only about 1% of the body's total magnesium, since the vast majority is stored inside cells and in bone, similar to the situation with calcium described in other contexts. This means blood levels can sometimes stay within a technically "normal" range even when a person's overall body magnesium stores have been meaningfully depleted by an ongoing medication effect, because the body works to protect blood levels at the expense of these deeper stores for as long as it reasonably can. Together, these two factors — magnesium not being routinely tested, and blood levels lagging behind true total-body depletion — mean that a person can be on a magnesium-wasting medication for a long time, genuinely deficient at the tissue level, and still have this go unrecognized until either a level is specifically checked or symptoms become pronounced enough to prompt more targeted testing.

Diuretics: The Most Common Medication-Related Cause

Figure 2. Loop and thiazide diuretics, among the most commonly prescribed medications for blood pressure and fluid retention, are also the leading medication-related cause of magnesium loss.

Diuretics, commonly known as "water pills," are prescribed for high blood pressure, heart failure, and fluid retention, and they represent the single most common medication-related cause of magnesium deficiency seen in clinical practice. Loop diuretics, a class that includes furosemide and similar drugs, work by blocking a specific transport protein in the thick ascending limb of the loop of Henle — the exact kidney segment responsible for reabsorbing the largest share of your body's magnesium. By blocking this transporter to achieve their intended effect of increasing sodium and water excretion (which is what lowers blood pressure and reduces fluid buildup), loop diuretics simultaneously and unavoidably block magnesium reabsorption at that same site, causing significantly more magnesium to be lost in urine than would normally occur.

Thiazide diuretics, another major class used primarily for high blood pressure, act at a different site along the nephron — the distal convoluted tubule — and cause magnesium loss through a somewhat different, less fully understood mechanism involving altered magnesium channel activity at that location. Thiazides tend to produce a milder degree of magnesium loss than loop diuretics for a given dose, but with long-term daily use, even this smaller per-day loss can accumulate into a meaningful deficiency over months or years, particularly in older adults or people with other risk factors like poor dietary intake or a diet already low in magnesium-rich foods to begin with, which can accelerate how quickly a clinically meaningful deficiency develops. Because both diuretic classes are so widely prescribed — loop and thiazide diuretics together are used by a substantial share of adults with hypertension or heart failure — this single mechanism accounts for a large proportion of all medication-related magnesium deficiency identified in clinical settings, which is why magnesium is one of several electrolytes routinely monitored in anyone on long-term diuretic therapy. Interestingly, a different class of diuretic — potassium-sparing diuretics, which work through yet another distinct mechanism at a different site along the nephron — generally do not cause significant magnesium loss and, in some cases, are even used specifically to help offset magnesium wasting when combined with a loop or thiazide diuretic, illustrating that "diuretic" is not a single uniform category when it comes to this particular side effect, and that the specific drug and mechanism involved matters considerably more than the broad class name alone.

Proton Pump Inhibitors and Acid-Reducing Medications

Figure 3. Proton pump inhibitors reduce stomach acid so effectively that they can impair the intestine's ability to absorb magnesium from food.

Proton pump inhibitors, or PPIs — a widely used class of medications for acid reflux, heartburn, and stomach ulcers that includes omeprazole and similar drugs — cause magnesium deficiency through an entirely different pathway than diuretics: reduced intestinal absorption rather than increased kidney loss. PPIs work by powerfully suppressing stomach acid production, which is exactly what makes them effective for their intended purpose, but stomach acid also plays a supporting role in how efficiently your intestines absorb magnesium from food. The exact absorption mechanism affected isn't fully settled in current research, but it's thought to involve changes to a specific intestinal magnesium transport channel that becomes less active when stomach acid is chronically suppressed.

What makes PPI-related magnesium deficiency notable is its timeline: unlike diuretic-related loss, which can develop relatively quickly, PPI-related deficiency typically takes much longer to become apparent, often only showing up after a year or more of continuous use, which is part of why this connection went underrecognized for years after PPIs first came into widespread use. It's also generally considered a class effect, meaning all PPIs carry this same risk to varying degrees, rather than being specific to one particular drug within the class. Because PPIs are commonly used long-term, sometimes for years at a stretch, and because the deficiency can be severe enough in some cases to cause significant symptoms, regulatory agencies in multiple countries have specifically flagged this interaction, and it's now standard practice for prescribers to consider periodic magnesium monitoring in patients on long-term PPI therapy, particularly if they're also taking a diuretic or another medication that independently lowers magnesium — since these effects can compound rather than simply add together. Some research has also looked at whether the specific type of PPI, or the dose used, changes the degree of risk, and while data suggests higher doses and longer durations do generally correlate with greater magnesium loss, the effect has been documented across essentially every drug in the PPI class, meaning switching from one PPI to another is unlikely to meaningfully reduce this particular risk on its own — unlike some other PPI-related side effects, where switching within the class can sometimes help.

Certain Antibiotics and Antifungals

Figure 4. Certain intravenous antibiotics and antifungals can directly injure the kidney's magnesium-reabsorbing tubules, particularly with prolonged or high-dose use.

A specific group of antibiotics called aminoglycosides — including gentamicin and similar drugs, typically given intravenously in a hospital setting for serious bacterial infections — are recognized causes of magnesium loss through a more direct mechanism: measurable injury to the kidney's tubule cells themselves, the same structures responsible for magnesium reabsorption described earlier. This tubular effect is generally reversible after the antibiotic course ends, but it can be significant during treatment, particularly with higher doses, longer treatment courses, or in patients who already have some degree of underlying kidney impairment, which is why magnesium and kidney function are both typically monitored during extended aminoglycoside therapy.

Amphotericin B, a potent antifungal medication reserved for serious, often life-threatening fungal infections, is well known for causing a similar pattern of kidney tubular injury, and magnesium wasting is one of its most consistently observed side effects — occurring in a majority of patients receiving the medication for more than a few days, to the point where clinicians managing amphotericin B treatment routinely anticipate and proactively monitor for it rather than waiting for symptoms to appear. Both of these drug classes illustrate an important distinction from diuretics and PPIs: rather than working through a predictable, mechanism-based side effect of the drug doing its intended job, these medications cause magnesium loss as a more incidental consequence of low-grade toxicity to kidney tissue, which is part of why the degree of magnesium loss can vary more unpredictably from person to person, depending on individual susceptibility and existing kidney health, and why closer monitoring is standard practice whenever these particular medications are used. In hospital settings, this typically means checking magnesium alongside routine kidney function tests every few days during treatment, allowing the care team to catch a declining trend and adjust supplementation before the deficiency becomes severe enough to cause noticeable symptoms or complications.

Chemotherapy Drugs That Affect Magnesium

Figure 5. Cisplatin, a widely used chemotherapy drug, is one of the most potent known causes of medication-related magnesium wasting through direct kidney tubule injury.

Cisplatin, one of the most widely used and effective chemotherapy drugs for a range of solid tumor cancers, is also one of the most well-documented and potent causes of medication-induced magnesium loss, affecting a large proportion of patients who receive it. Like aminoglycosides and amphotericin B, cisplatin causes direct injury to the kidney's tubule cells, but its effect on magnesium handling tends to be more pronounced and, notably, can persist for months to years after treatment ends in some patients, rather than resolving quickly once the drug is stopped — a distinction that makes ongoing magnesium monitoring an important part of long-term follow-up care for cancer survivors who received cisplatin-based treatment.

Because cisplatin's magnesium-wasting effect is so well established and so common, oncology teams typically build magnesium monitoring and, often, proactive magnesium supplementation directly into the treatment protocol from the start, rather than waiting for a low level to show up on routine labs before addressing it — a good example of how well-understood medication side effects can be managed proactively rather than reactively once the mechanism is clearly known. Many oncology protocols include magnesium and other electrolyte checks before each cisplatin cycle, with supplementation adjusted based on that result rather than a fixed dose given regardless of the patient's actual status — an approach that reflects just how consistently predictable this particular side effect has proven to be across large numbers of patients over decades of clinical use, and how thoroughly it has been characterized in the medical literature compared to some of the newer, less-studied medications discussed elsewhere in this article. Other chemotherapy drugs, including some in the same platinum-based family as cisplatin and certain targeted cancer therapies affecting the epidermal growth factor receptor (EGFR) pathway, have also been associated with magnesium loss through related or distinct mechanisms, which is part of why a comprehensive electrolyte panel, including magnesium, is a standard component of routine monitoring throughout many chemotherapy regimens.

Immunosuppressants and Other Medications Worth Knowing About

Figure 6. Calcineurin inhibitors, essential anti-rejection medications after organ transplantation, are a well-recognized cause of ongoing magnesium loss requiring long-term monitoring.

Calcineurin inhibitors — a class of immunosuppressant medications including cyclosporine and tacrolimus, used primarily to prevent organ rejection after transplantation — are another well-established cause of magnesium wasting, again through direct interference with kidney tubule magnesium handling. Because these medications are typically needed for years, sometimes for the rest of a transplant recipient's life, magnesium deficiency in this population tends to be a chronic, ongoing management issue rather than a temporary side effect that resolves once treatment ends, which is why magnesium is one of the standard labs checked at essentially every follow-up visit for transplant recipients on these medications. Transplant teams typically incorporate oral magnesium supplementation as a routine, expected part of post-transplant care from early on, rather than waiting for a documented low level to appear first, precisely because the underlying mechanism is so well established and so consistently observed across the transplant population as a whole.

A handful of other medications round out the more commonly recognized causes worth knowing about: insulin, particularly at high doses, can shift magnesium from the blood into cells rather than causing true body-wide depletion, producing a temporary lab-value drop that doesn't reflect a genuine overall deficiency. Digoxin, a heart medication, doesn't directly lower magnesium but becomes considerably more dangerous when magnesium is already low, since magnesium deficiency increases the heart's sensitivity to digoxin's effects on rhythm — making magnesium monitoring especially important in anyone taking both digoxin and a magnesium-wasting diuretic together, a combination that isn't uncommon in patients with heart failure. Bisphosphonates, used for osteoporosis, and certain long-term laxative regimens have also been associated with lower magnesium in some patients, generally through less pronounced or less consistently documented mechanisms compared to the drug classes described above. Some corticosteroids, used for a wide range of inflammatory and autoimmune conditions, have similarly been linked to modest increases in urinary magnesium loss with long-term use, though this effect tends to be smaller and less consistently observed than with the medication classes discussed earlier in this article.

Special Populations: Older Adults and People With Kidney Disease

Certain groups face a meaningfully higher risk from these same medication mechanisms, worth understanding on their own terms. Older adults are more likely to be on several of the medications discussed here simultaneously — it's not uncommon for someone in their 70s or 80s to be taking a diuretic for blood pressure, a PPI for reflux, and perhaps other medications on top of that, stacking multiple independent magnesium-lowering mechanisms at once. Older adults also tend to have lower baseline dietary magnesium intake and reduced intestinal absorption efficiency simply as a function of aging, meaning the same medication-related loss that a younger, otherwise healthy person might tolerate without much consequence can push an older adult into more clinically significant deficiency more easily and more quickly.

People with underlying kidney disease represent a more complex, sometimes counterintuitive picture. In earlier stages of chronic kidney disease, the same medications that cause magnesium wasting in people with normal kidney function can still do so, sometimes to a similar or even greater degree, since the affected tubule segments are often still functioning enough to lose magnesium even as overall kidney function has partly declined. However, in more advanced kidney disease, the kidneys can lose enough overall filtering capacity that they're no longer able to excrete magnesium efficiently at all, which can occasionally result in magnesium building up rather than dropping, especially if a person is also taking magnesium-containing supplements or antacids without their kidney function being taken into account. This is exactly why magnesium management in people with significant kidney disease requires more individualized, careful attention rather than following the same general rules that apply to people with normal kidney function.

How to Recognize Medication-Related Magnesium Loss

The symptoms of medication-related magnesium deficiency are identical to magnesium deficiency from any other cause, since the underlying biological consequence — not having enough magnesium available for its many essential functions — is the same regardless of why the deficiency developed. Early or mild symptoms tend to be vague and easy to attribute to something else: fatigue, mild muscle cramps or twitching, loss of appetite, and nausea are all common early signs that many people, understandably, don't immediately connect to a medication they may have been taking safely for months or years already. As deficiency becomes more pronounced, more specific neuromuscular symptoms can appear, including more significant muscle cramping, tremor, and in some cases numbness or tingling sensations similar to those seen with low calcium — which makes sense given how closely magnesium and calcium regulation are intertwined at the cellular level.

In more severe cases, magnesium deficiency can affect heart rhythm, potentially causing palpitations or more serious arrhythmias, and can also cause low calcium and low potassium as secondary effects, since magnesium is required for both normal parathyroid hormone function (which regulates calcium) and normal potassium channel function in cells — meaning a medication-related magnesium problem can sometimes present initially as an unexplained low calcium or low potassium result rather than an obviously low magnesium one, adding another layer of complexity to recognizing what's actually going on. This is precisely why, when someone on a known magnesium-wasting medication develops any of these symptoms, or when routine labs reveal an unexplained drop in calcium or potassium alongside a medication history that includes any of the drug classes described above, checking magnesium specifically is a logical and often revealing next step, even if magnesium itself wasn't the test that originally prompted concern.

Tracking Magnesium Over Time While on These Medications

Because medication-related magnesium loss tends to be gradual and cumulative rather than sudden, tracking levels over time — rather than relying on a single test — gives a much clearer picture of what's actually happening than any one result in isolation. For someone starting a new long-term diuretic, PPI, or immunosuppressant, a reasonable baseline magnesium check before or shortly after starting, followed by periodic rechecks at intervals appropriate to the specific medication and individual risk factors, allows a downward trend to be caught and addressed well before it becomes severe enough to cause symptoms or complications that are harder to reverse. This kind of proactive monitoring is especially valuable given how nonspecific early symptoms of magnesium deficiency tend to be — catching a gradually declining level on a lab trend often happens well before a person would otherwise notice or report anything unusual.

For people on medications with a well-established, predictable magnesium-wasting effect — cisplatin chemotherapy and calcineurin inhibitors being the clearest examples — monitoring is typically built directly into the standard treatment protocol from the outset, with magnesium checked at nearly every visit for as long as the medication continues, and often for some time afterward as well. For medications with a more variable or slower-developing effect, like PPIs and thiazide diuretics, monitoring tends to be less frequent but still periodic, particularly once someone has been on the medication for a year or longer, or if they're also taking another medication known to affect magnesium. In all these cases, the underlying principle is the same: a single normal magnesium result doesn't guarantee the level will stay that way indefinitely on an ongoing medication, and continued monitoring is what actually protects against the deficiency quietly progressing unnoticed.

What to Do If Your Medication Is Lowering Your Magnesium

Figure 7. Managing medication-related magnesium loss typically involves monitoring, dietary adjustment, or targeted supplementation — rarely a change to the medication itself.

The single most important thing to understand if a medication is identified as the cause of low magnesium is that this finding, on its own, is very rarely a reason to stop taking that medication — the medications most commonly involved (diuretics, PPIs, chemotherapy, immunosuppressants) are typically prescribed for conditions where the benefit substantially outweighs this manageable side effect, and stopping a blood pressure medication or an anti-rejection drug because of a correctable electrolyte issue would generally trade a smaller, fixable problem for a much larger one. Instead, management typically involves oral magnesium supplementation, adjusted based on the severity of the deficiency and how well it's tolerated (since magnesium supplements can cause diarrhea at higher doses, which itself can worsen magnesium loss through the gut), alongside dietary changes emphasizing magnesium-rich foods like leafy greens, nuts, seeds, and whole grains.

For more severe or symptomatic deficiency, particularly in a hospital setting, intravenous magnesium replacement may be used to correct the level more quickly and reliably than oral supplementation alone can achieve. Ongoing monitoring — periodic magnesium checks, spaced according to how high-risk the specific medication and patient combination is — allows the level to be tracked over time and the supplementation plan adjusted as needed, rather than treating it as a one-time fix. In some cases, if magnesium loss is severe and difficult to manage despite supplementation, a prescriber may consider switching to an alternative medication within the same drug class that carries a somewhat lower magnesium-wasting risk, though this decision always weighs the full clinical picture rather than being made on the basis of magnesium alone. The most important practical takeaway is simple: never stop or adjust a prescribed medication on your own because of a low magnesium result — instead, bring the result and your full medication list to whoever prescribed it, so the two can be evaluated together and the right management plan can be built around both. A pharmacist can also be a valuable resource in this conversation, since reviewing a full medication list specifically for magnesium-affecting drugs, including over-the-counter medications and supplements a person might not think to mention to their primary prescriber, is exactly the kind of medication-reconciliation task pharmacists are trained to do well, and many are glad to walk through this with a patient who brings a genuine question about it.

How Magnesium, Calcium, and Potassium Interact With Each Other

One of the reasons medication-related magnesium deficiency can be trickier to fully understand than it first appears is that magnesium doesn't operate in isolation — it's closely intertwined with two other electrolytes, calcium and potassium, in ways that can either mask or amplify the clinical picture. Magnesium is genuinely, directly required for the parathyroid glands to release parathyroid hormone (PTH) properly and effectively, the hormone responsible for raising blood calcium when it drops. When magnesium is significantly low, PTH release becomes impaired, which means the body's normal calcium-defense system essentially stalls — leading to low calcium that won't fully correct with calcium supplementation alone until the underlying magnesium deficiency is addressed first, a pattern that has caught more than a few clinicians off guard when a patient's calcium simply won't budge despite seemingly appropriate treatment.

Magnesium also plays a direct role in how potassium is retained inside cells versus lost through the kidneys, through its effect on a specific class of potassium channels. Significant magnesium deficiency can cause potassium to leak out of cells and be lost in urine more readily, producing low potassium that, similarly to the calcium situation, tends to resist correction with potassium supplementation alone until magnesium is also corrected. This three-way relationship between magnesium, calcium, and potassium is exactly part of why experienced clinicians who see a stubbornly low calcium or potassium result that isn't responding as expected to otherwise straightforward, appropriate treatment will often specifically check magnesium next, even if magnesium wasn't part of the original concern — recognizing that these three electrolytes are functionally linked rather than fully independent of one another, especially in situations, like several of the medications discussed in this article, that put direct, sustained pressure on magnesium balance in the first place. Recognizing this interconnected relationship is often what finally resolves a confusing case where calcium or potassium levels have seemed stubbornly resistant to otherwise reasonable, correctly dosed treatment for no apparent reason.

Frequently Asked Questions

Conclusion

Several widely used medications can genuinely and predictably lower magnesium, each through its own specific mechanism — diuretics and certain antibiotics by increasing how much the kidneys excrete, PPIs by reducing how much the intestines absorb, and drugs like cisplatin and calcineurin inhibitors through more direct injury to the kidney's magnesium-handling structures. None of this is a reason to panic or to stop a needed medication on your own, but it is a good reason to recognize the connection when it applies to you, to bring it up with whoever manages your prescriptions, and to make sure magnesium gets checked periodically if you're on one of these medications long-term. Understanding the mechanism behind a low result — rather than treating it as an isolated, unexplained number — is what turns a confusing lab finding into a clear, manageable part of your overall care, and in the great majority of cases, once identified, this particular issue is straightforward to address alongside the medication that's genuinely helping you.

This article is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider regarding your specific lab results.

Related Articles